Our results reveal that after PbA-infection, the microglial production of IL-1β which affects neurogenesis and causes cognitive impairments, is mediated by IL-33/ST2 pathway, prior to the apparition of ECM-induced clinical neurological symptoms. Here, IL33 is linked to infection.